Valneva SE is a specialty vaccine company that develops, manufactures and commercializes preventive vaccines for infectious diseases where medical needs remain unmet. Its travel-health business includes three commercial vaccines, among them a single-shot chikungunya vaccine, while its research pipeline reaches into diseases such as Lyme disease, Shigella and Zika. With more than 650 employees across six countries and in-house manufacturing operations in Scotland, Sweden and Austria, Valneva combines vaccine development with production and clinical-services capabilities.
Good Manufacturing Practice (GMP)
compliance_program
FDA Approved Manufacturing Site
compliance_program